ID: ALA4754250

Max Phase: Preclinical

Molecular Formula: C15H10F3NO3

Molecular Weight: 309.24

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1ccccc1C(=O)O)c1ccc(C(F)(F)F)cc1

Standard InChI:  InChI=1S/C15H10F3NO3/c16-15(17,18)10-7-5-9(6-8-10)13(20)19-12-4-2-1-3-11(12)14(21)22/h1-8H,(H,19,20)(H,21,22)

Standard InChI Key:  QTXWTCKVSMDZIQ-UHFFFAOYSA-N

Associated Targets(Human)

Potassium channel subfamily K member 10 76 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Potassium channel subfamily K member 2 490 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 309.24Molecular Weight (Monoisotopic): 309.0613AlogP: 3.66#Rotatable Bonds: 3
Polar Surface Area: 66.40Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.55CX Basic pKa: CX LogP: 4.25CX LogD: 0.89
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.91Np Likeness Score: -1.26

References

1. Iwaki Y,Yashiro K,Kokubo M,Mori T,Wieting JM,McGowan KM,Bridges TM,Engers DW,Denton JS,Kurata H,Lindsley CW.  (2019)  Towards a TREK-1/2 (TWIK-Related K+ Channel 1 and 2) dual activator tool compound: Multi-dimensional optimization of BL-1249.,  29  (13.0): [PMID:31072652] [10.1016/j.bmcl.2019.04.048]

Source